Loading organizations...
§ Private Profile · Chicago, IL, USA
Healthcare SaaS platform offering drug discount management for pharmaceutical manufacturers, providers, and payers, focused on compliance and.
Kalderos, based in Chicago, Illinois, provides a SaaS-based Drug Discount Management platform that leverages AI, data analytics, and machine learning to ensure compliance in drug discount and rebate programs. The platform serves pharmaceutical manufacturers, including 7 of the 15 largest, and over 2,500 healthcare providers, pharmacies, state Medicaid programs, and payers, enabling them to identify non-compliant claims and resolve disputes. The company has raised $35 million in total funding, including a $28 million Series B round in March 2021 led by Bain Capital Ventures and Mercato Partners. Kalderos has reviewed over 500,000 discount requests, identifying $100 million in duplicated discounts, and reported 60 employees as of 2021. It was founded in 2016 by Jeremy Docken, Jim Bonkowski, and David De Vogel.
Kalderos has raised $50.0M across 3 funding rounds.
Kalderos has raised $50.0M in total across 3 funding rounds.
Kalderos has raised $50.0M across 3 funding rounds. Most recently, it raised $15.0M Series U in September 2022.
| Date | Round | Lead Investors | Other Investors | Status |
|---|---|---|---|---|
| Sep 1, 2022 | $15M Series U | — | Alumni Ventures, Tribe Capital, Uprising, Matt Mazzeo | Announced |
| Jun 1, 2020 | $28M Series B | — | Bain Capital Ventures, Mercato Partners | Announced |
| May 8, 2019 | $7M Series A | Mercato Partners | — | Announced |
Kalderos is a healthcare technology company founded in 2016 that builds the world’s first Drug Discount Management platform. It serves healthcare providers, drug manufacturers, payers, and government agencies by using data infrastructure, artificial intelligence, and machine learning to improve transparency, compliance, and efficiency in drug discount programs such as the 340B program. The platform helps eliminate waste and noncompliance by analyzing claims and facilitating better collaboration among stakeholders. Kalderos has processed over 1 million claims for approximately 4,200 safety net providers and is experiencing strong growth, with provider engagement increasing 20-fold since 2018 and revenue on track to double in 2022[1][4][6][7].
Kalderos was founded in 2016 in Chicago by a team focused on solving systemic inefficiencies in the U.S. healthcare drug discount ecosystem. The founders identified the complexity and opacity in drug discount programs, which led to costly noncompliance and disputes. They developed a technology platform leveraging big data and AI to bring transparency, trust, and equity to drug discount management. Early traction came from successfully enabling safety net providers and manufacturers to communicate more effectively and resolve compliance issues, positioning Kalderos as a pioneer in this niche healthcare technology space[1][4][6].
Kalderos rides the growing trend of applying AI and big data analytics to healthcare administration, particularly in drug pricing and compliance—a sector plagued by complexity and inefficiency. The timing is critical as regulatory scrutiny and healthcare costs rise, increasing demand for transparent, technology-driven solutions. By enabling better collaboration and compliance in drug discount programs, Kalderos helps reduce waste and fraud, contributing to a more sustainable healthcare system. Its platform influences the broader ecosystem by setting new standards for data sharing and operational transparency among diverse healthcare stakeholders[1][4][6].
Kalderos is poised to expand its influence as healthcare systems increasingly adopt AI-driven compliance and financial management tools. Future growth will likely be shaped by ongoing regulatory changes, increasing demand for transparency in drug pricing, and broader adoption of cloud-based healthcare solutions. The company’s continued innovation in AI and collaboration tools positions it to deepen its impact on drug discount programs and potentially expand into related healthcare financial management areas. As Kalderos scales, it may become a critical infrastructure provider for drug discount compliance, helping the healthcare industry focus more on patient outcomes rather than administrative dysfunction[1][4][6][7].
Kalderos has raised $50.0M in total across 3 funding rounds.
Kalderos's investors include Alumni Ventures, Tribe Capital, Uprising, Matt Mazzeo, Bain Capital Ventures, Mercato Partners.